195 related articles for article (PubMed ID: 6316394)
1. Effect of selective monoamine oxidase inhibition by clorgyline and deprenyl on the norepinephrine receptor-coupled adenylate cyclase system in rat cortex.
Mishra R; Gillespie DD; Youdim MB; Sulser F
Psychopharmacology (Berl); 1983; 81(3):220-3. PubMed ID: 6316394
[TBL] [Abstract][Full Text] [Related]
2. Changes in alpha- and beta-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants.
Cohen RM; Campbell IC; Dauphin M; Tallman JF; Murphy DL
Neuropharmacology; 1982 Apr; 21(4):293-8. PubMed ID: 6123960
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
4. Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase.
Palfreyman MG; Mir AK; Kubina M; Middlemiss DN; Richards M; Tricklebank MD; Fozard JR
Eur J Pharmacol; 1986 Oct; 130(1-2):73-89. PubMed ID: 3780861
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
6. Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase.
Sleight AJ; Marsden CA; Palfreyman MG; Mir AK; Lovenberg W
Eur J Pharmacol; 1988 Sep; 154(3):255-61. PubMed ID: 3234480
[TBL] [Abstract][Full Text] [Related]
7. Chronic effects of a monoamine oxidase-inhibiting antidepressant: decreases in functional alpha-adrenergic autoreceptors precede the decrease in norepinephrine-stimulated cyclic adenosine 3': 5'-monophosphate systems in rat brain.
Cohen RM; Ebstein RP; Daly JW; Murphy DL
J Neurosci; 1982 Nov; 2(11):1588-95. PubMed ID: 6292376
[TBL] [Abstract][Full Text] [Related]
8. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
9. Daily bupropion injections for 3 weeks attenuate the NE stimulation of adenylate cyclase and the number of beta-adrenergic recognition sites in rat frontal cortex.
Gandolfi O; Barbaccia ML; Chuang DM; Costa E
Neuropharmacology; 1983 Jul; 22(7):927-9. PubMed ID: 6312356
[TBL] [Abstract][Full Text] [Related]
10. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.
Blier P; De Montigny C; Azzaro AJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):987-94. PubMed ID: 2423685
[TBL] [Abstract][Full Text] [Related]
11. Development of and recovery from subsensitivity of the noradrenergic cyclic AMP generating system in brain. Effect of amphetamine following inhibition of its aromatic hydroxylation by iprindole.
Manier DH; Gillespie DD; Sulser F
Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):113-8. PubMed ID: 6252479
[TBL] [Abstract][Full Text] [Related]
12. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological and receptor studies in rat brain: effects of clorgyline.
Campbell IC; Gallager DW; Hamburg MA; Tallman JF; Murphy DL
Eur J Pharmacol; 1985 May; 111(3):355-64. PubMed ID: 2990957
[TBL] [Abstract][Full Text] [Related]
14. Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
Kumagae Y; Matsui Y; Iwata N
Jpn J Pharmacol; 1991 Jan; 55(1):121-8. PubMed ID: 1904113
[TBL] [Abstract][Full Text] [Related]
15. Properties of monoamine oxidase in monkey heart.
Katayama M; Kobayashi S; Oguchi K; Yasuhara H
Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
[TBL] [Abstract][Full Text] [Related]
16. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
Glover V; Pycock CJ; Sandler M
Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase substrates and substrate affinity.
Domino EF
Schizophr Bull; 1980; 6(2):292-7. PubMed ID: 6769148
[TBL] [Abstract][Full Text] [Related]
18. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
Kan JP; Steinberg R; Mouget-Goniot C; Worms P; Bizière K
J Pharmacol Exp Ther; 1987 Jan; 240(1):251-8. PubMed ID: 3100771
[TBL] [Abstract][Full Text] [Related]
19. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
Schoepp DD; Azzaro AJ
J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
